Cambridge Investment Research Advisors, Inc. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$6,476
-23.4%
63,580
-24.1%
0.03%
-21.1%
Q2 2023$8,449
+69.3%
83,727
+54.4%
0.04%
+58.3%
Q1 2023$4,990
-2.3%
54,239
-3.7%
0.02%
-7.7%
Q4 2022$5,108
-99.9%
56,304
-0.2%
0.03%
+8.3%
Q3 2022$4,287,000
-11.4%
56,403
-1.4%
0.02%
-7.7%
Q2 2022$4,837,000
+1.6%
57,226
+5.5%
0.03%
+18.2%
Q1 2022$4,760,000
+0.1%
54,240
-0.2%
0.02%
+4.8%
Q4 2021$4,754,000
+15.8%
54,346
+8.3%
0.02%
+5.0%
Q3 2021$4,104,000
-17.0%
50,184
-7.4%
0.02%
-16.7%
Q2 2021$4,947,000
-0.7%
54,219
-7.0%
0.02%
-11.1%
Q1 2021$4,983,000
-8.5%
58,290
+1.1%
0.03%
-15.6%
Q4 2020$5,443,000
-6.1%
57,639
-13.5%
0.03%
-17.9%
Q3 2020$5,798,000
+5.2%
66,672
+5.7%
0.04%
-4.9%
Q2 2020$5,509,000
+7.1%
63,078
+1.1%
0.04%
-16.3%
Q1 2020$5,143,000
-4.8%
62,378
+9.4%
0.05%
+16.7%
Q4 2019$5,400,000
+16.8%
57,023
+7.2%
0.04%
+2.4%
Q3 2019$4,624,000
+6.2%
53,207
+11.6%
0.04%
+2.5%
Q2 2019$4,354,000
-43.4%
47,678
-40.5%
0.04%
-45.9%
Q1 2019$7,699,000
+89.8%
80,086
+69.4%
0.07%
+64.4%
Q4 2018$4,056,000
+4.2%
47,269
+4.6%
0.04%
+21.6%
Q3 2018$3,894,000
+17.5%
45,193
+3.0%
0.04%
+5.7%
Q2 2018$3,313,000
-12.9%
43,862
-6.8%
0.04%
-18.6%
Q1 2018$3,805,000
-0.2%
47,058
+3.6%
0.04%
-4.4%
Q4 2017$3,814,000
-0.6%
45,425
+1.6%
0.04%
-13.5%
Q3 2017$3,838,000
+16.3%
44,709
+13.1%
0.05%
+6.1%
Q2 2017$3,300,000
+14.7%
39,530
+2.1%
0.05%0.0%
Q1 2017$2,876,000
+1.0%
38,726
-0.9%
0.05%
-7.5%
Q4 2016$2,847,000
+0.9%
39,089
+9.4%
0.05%
+1.9%
Q3 2016$2,822,000
-4.0%
35,735
+0.3%
0.05%
-16.1%
Q2 2016$2,940,000
+24.5%
35,628
+9.3%
0.06%
+17.0%
Q1 2016$2,362,000
-13.5%
32,602
+2.8%
0.05%
-18.5%
Q4 2015$2,730,000
-8.0%
31,729
-1.8%
0.06%
-23.5%
Q3 2015$2,969,000
-6.1%
32,295
+0.5%
0.08%
-2.3%
Q2 2015$3,162,000
+9.8%
32,149
+10.0%
0.09%
+6.1%
Q1 2015$2,881,000
+8.0%
29,218
+1.5%
0.08%
-1.2%
Q4 2014$2,668,000
+0.9%
28,795
+2.5%
0.08%
+6.4%
Q3 2014$2,645,000
+29.7%
28,096
+24.7%
0.08%
+9.9%
Q2 2014$2,039,000
+9.6%
22,523
+2.9%
0.07%
+1.4%
Q1 2014$1,861,000
-4.0%
21,889
-9.2%
0.07%
-11.4%
Q4 2013$1,938,000
+16.0%
24,115
+10.7%
0.08%
+8.2%
Q3 2013$1,671,000
+17.9%
21,782
+8.7%
0.07%
+1.4%
Q2 2013$1,417,00020,0450.07%
Other shareholders
NOVARTIS A G shareholders Q4 2020
NameSharesValueWeighting ↓
Newman Dignan & Sheerar, Inc. 3,739$353,074,00056.77%
Susquehanna International Securities, Ltd. 118,837$11,222,0008.15%
MANAGED ASSET PORTFOLIOS, LLC 336,762$31,800,0005.59%
Martin Investment Management, LLC 169,019$15,960,0005.10%
SCHARF INVESTMENTS, LLC 1,197,539$113,083,0004.26%
GARLAND CAPITAL MANAGEMENT INC 50,705$4,788,0004.06%
Mawer Investment Management Ltd. 6,625,594$625,655,0003.69%
SPHERA FUNDS MANAGEMENT LTD. 429,000$40,510,0003.60%
First Fiduciary Investment Counsel, Inc. 196,693$18,574,0003.48%
PROFESSIONAL ADVISORY SERVICES INC 227,971$21,527,0003.46%
View complete list of NOVARTIS A G shareholders